Myriad Genetics, Inc.

MYGN

$3.23

+0.00%

2026-09-03 16:00:01 EDT+$0.00

Healthcare

Medical - Diagnostics & Research

NASDAQ

Active Trading

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Samraat S. Raha	President, Chief Executive Officer & Director	USD 1,697,011		1973	Active
Paul J. Diaz	Consultant	USD 1,524,843		1962	Active
Brian Donnelly	Chief Commercial Officer	USD 1,198,247		1983	Active
Mark S. Verratti	Chief Operating Officer	USD 1,087,182		1968	Active
Benjamin R. Wheeler	Chief Financial Officer & Principal Accounting Officer	USD 748,668		1984	Active
Dale Muzzey	Chief Scientific Officer	USD 741,858	—	1980	Active
Raj Jampa	Chief Technology Officer	USD 580,360		—	Active
Patrick Burke	Executive Vice President of Corporate & Business Development	—	—	—	Active
Matthew Scalo	Senior Vice President of Investor Relations	—		—	Active
Jennifer L. Fox	Chief Legal Officer	—		1973	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-14	2025	Brian J. Donnelly	Chief Chief Commercial Officer	C-Level	$350.00K	$450.00K	$4.80M	$0	$371.91K	$26.34K	$6.00M
2026-04-14	2025	Samraat S. Raha	President President and Chief Chief Executive Officer	Founder / CEO	$856.90K	$0	$3.99M	$0	$814.66K	$25.45K	$5.69M
2026-04-14	2025	Mark S. Verratti	Chief Chief Operating Officer	C-Level	$622.88K	$0	$2.06M	$0	$438.32K	$25.98K	$3.15M
2026-04-14	2025	Scott J. Leffler	Former Former Chief Chief Financial Officer	C-Level	$393.80K	$0	$1.07M	$0	$0	$1.28M	$2.74M
2026-04-14	2025	Margaret Ancona	Former Former EVP, Strategy and Transformation	Other	$330.85K	$0	$800.75K	$0	$0	$763.56K	$1.90M
2026-04-14	2025	Dale Muzzey, Ph.D.	Chief Chief Scientific Officer	C-Level	$506.40K	$0	$1.12M	$0	$221.68K	$13.78K	$1.86M
2026-04-14	2025	Benjamin R. Wheeler	Chief Chief Financial Officer	C-Level	$408.49K	$0	$759.23K	$0	$325.42K	$14.75K	$1.51M
2026-04-14	2025	Paul J. Diaz	Former Former President President and Chief Chief Executive Officer	Founder / CEO	$418.10K	$0	$0	$0	$0	$270.53K	$688.64K
2026-04-14	2024	Paul J. Diaz	Former Former President President and Chief Chief Executive Officer	Founder / CEO	$1.12M	$0	$11.11M	$0	$1.36M	$39.46K	$13.63M
2026-04-14	2024	Scott J. Leffler	Former Former Chief Chief Financial Officer	C-Level	$487.57K	$400.00K	$4.79M	$0	$428.54K	$44.46K	$6.15M
2026-04-14	2024	Samraat S. Raha	President President and Chief Chief Executive Officer	Founder / CEO	$750.00K	$0	$2.91M	$0	$706.50K	$22.15K	$4.39M
2026-04-14	2024	Mark S. Verratti	Chief Chief Operating Officer	C-Level	$552.34K	$0	$2.65M	$0	$489.72K	$24.07K	$3.71M
2026-04-14	2024	Dale Muzzey, Ph.D.	Chief Chief Scientific Officer	C-Level	$499.35K	$0	$2.22M	$0	$265.10K	$18.73K	$3.01M
2026-04-14	2023	Paul J. Diaz	Former Former President President and Chief Chief Executive Officer	Founder / CEO	$1.09M	$0	$9.80M	$0	$1.17M	$56.72K	$12.11M
2026-04-14	2023	Samraat S. Raha	President President and Chief Chief Executive Officer	Founder / CEO	$14.37K	$500.00K	$4.50M	$0	$0	$390	$5.02M
2026-04-14	2023	Mark S. Verratti	Chief Chief Operating Officer	C-Level	$495.78K	$0	$1.96M	$0	$400.25K	$19.78K	$2.88M
2026-04-14	2023	Dale Muzzey, Ph.D.	Chief Chief Scientific Officer	C-Level	$443.75K	$111.04K	$1.42M	$0	$250.65K	$11.07K	$2.23M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of MYGN

RELATIONS

Upstream

Illumina, Inc.NASDAQ:ILMN QIAGEN N.V.NYSE:QGENUltima GenomicsSOPHiA GENETICS SANASDAQ:SOPHPATHOMIQ, Inc.Thermo Fisher Scientific, Inc.NYSE:TMO Personalis, Inc.NASDAQ:PSNL Agilent Technologies, Inc.NYSE:A

Downstream

AstraZeneca plcNASDAQ:AZN Merck & Co., Inc.NYSE:MRK Pfizer Inc.NYSE:PFE BeiGene, Ltd.NASDAQ:BGNE The US Oncology Network (McKesson Corporation)NYSE:MCK UnitedHealth Group (UnitedHealthcare)NYSE:UNH Elevance Health (Anthem Blue Cross)NYSE:ELVCenters for Medicare & Medicaid Services (CMS)

Proxies

Natera, Inc.NASDAQ:NTRA Exact Sciences CorporationNASDAQ:EXAS Guardant Health, Inc.NASDAQ:GHInvitae Corporation (now part of Labcorp)Unconfirmed

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer